Press Releases Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-09 pm EDT			5-day change	1st Jan Change
376.97 ^USD	+2.01%		-2.26%	+15.17%

Mar. 09	Global drugmakers rush to boost US presence as tariff threat looms	RE
Mar. 05	Arcutis Biotherapeutics, Inc. Announces Promotion of Mas Matsuda to Executive Vice President, Chief Legal Officer, and Corporate Secretary	CI

Press Releases

Mar. 05	AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE	PR
Mar. 04	AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND	PR
Feb. 27	FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN	AQ
Feb. 24	AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE	PR
Feb. 16	Hikma Launches Denosumab Biosimilars ENOBY And XTRENBO	AQ
Feb. 13	AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT	PR
Feb. 12	Amgen : European Commission Approves Amgen's UPLIZNA® For Generalized Myasthenia Gravis	PU
Feb. 11	USPTO Restores Strict RPI Filing Date Rule	AQ
Feb. 09	Amgen : When Advocacy Meets Science in the Care of People Living with gMG	PU
Feb. 03	Amgen : Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report	PU
Feb. 03	Amgen : Q4 2025 - Earnings Call Slides	PU
Feb. 03	Amgen: Q4 Earnings Snapshot	AQ
Feb. 03	AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS	PR
Feb. 02	Amgen : How Patients and Supportive Care Partners Work Together to Turn Their World Right-Side-Up After a Cancer Diagnosis	PU
Feb. 02	Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis	AQ
Jan. 28	AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS	PR
Jan. 12	Amgen : 2026 JP Morgan Healthcare Conference Presentation (01.12.26 0900AM)	PU
Jan. 07	AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	PR
Jan. 06	AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE	PR
Dec. 31	UPC Aligns With The EPO In Allowing Functional Antibody Claims	AQ
Dec. 19	AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS	PR
Dec. 11	FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS	PR
Dec. 09	AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND	PR
Dec. 08	Formulation Fight: Amgen Case Tests Patentability Of Biopharmaceuticals In India	AQ
Nov. 26	Real-World Evidence [RWE] Demonstrates Repatha's Long-Term Cardiovascular Benefits	AQ